Pramipexole 0.5mg Tablet PCD Pharma Franchise Hyderabad

Pramipexole 0.5mg Tablet Manufacturing Company Ahmedabad

Pramipexole 0.5mg Tablet Neuro Care Franchise Pune

Pramipexole 0.5mg Tablet Pharma Supplier Jaipur

Pramipexole 0.5mg Tablet Export Company Lucknow
Pramipexole 0.5mg Tablet Franchise Opportunity Chennai

Home/Products /pramipexole-dihydrochloride-ip-point-5mg-tablet

About the Product

Description


Pramiset 0.5 Tablet contains Pramipexole, a medicine used to help control movement problems. It works by acting on certain brain chemicals (dopamine receptors), improving muscle control and reducing symptoms such as shaking, stiffness, slow movements, and difficulty in balance. Doctors usually prescribe it for Parkinson’s disease and Restless Legs Syndrome (RLS) to improve quality of life and make daily activities easier.

Common side effects include drowsiness, dizziness, nausea, constipation, and fatigue. Some people may experience sudden sleep episodes, hallucinations, or low blood pressure when standing up. Report any unusual mood or behavior changes to your doctor.

Management of Parkinson’s disease Treatment of Restless Legs Syndrome (RLS)

Take Pramiset 0.5 Tablet exactly as prescribed by your doctor. Do not stop suddenly as it may worsen symptoms. This medicine can cause sleepiness or sudden sleep attacks; avoid driving or operating heavy machinery until you know how it affects you. Inform your doctor if you have kidney problems, heart disease, or a history of mental health issues before starting this medicine.

Store in a cool, dry place below 30°C, away from moisture and sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pramipexole Dihydrochloride I.P. 0.5mg Tablet in the PCD pharma franchise market?

Pramipexole 0.5mg Tablet has strong demand in the neurology and movement disorder segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neurological care portfolios.

Why should medical distributors include Pramipexole 0.5mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of Parkinson’s disease and Restless Legs Syndrome (RLS). Pramipexole 0.5mg is a dopamine agonist that helps improve motor control and reduce tremors and stiffness Used in neurologist-supervised chronic therapy This strengthens a reliable neurology-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pramipexole 0.5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from neurologist prescriptions, long-term chronic patient demand, hospital and specialty clinic supply, reliable supply chain support, and good margins in neurology medicines.

How can I become a distributor or franchise partner for Pramipexole 0.5mg Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.